Updates on clinical use of liquid biopsy in colorectal cancer screening, diagnosis, follow-up, and treatment guidance

O Mazouji, A Ouhajjou, R Incitti… - Frontiers in Cell and …, 2021 - frontiersin.org
Colorectal cancer (CRC) is one of the most common cancers worldwide, being the third most
diagnosed in the world and the second deadliest. Solid biopsy provides an essential guide …

Clinical multi-omics strategies for the effective cancer management

BC Yoo, KH Kim, SM Woo, JK Myung - Journal of proteomics, 2018 - Elsevier
Cancer is a global health issue as a multi-factorial complex disease, and early detection and
novel therapeutic strategies are required for more effective cancer management. With the …

Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics

H Lai, Y Liu, J Wu, J Cai, H Jie, Y Xu… - Frontiers in …, 2022 - frontiersin.org
Inflammatory processes are essential for innate immunity and contribute to carcinogenesis
in various malignancies, such as colorectal cancer, esophageal cancer and lung cancer …

Predictive and prognostic value of oncogene mutations and microsatellite instability in locally-advanced rectal cancer treated with neoadjuvant radiation-based …

E De Mattia, J Polesel, S Mezzalira, E Palazzari… - Cancers, 2023 - mdpi.com
Simple Summary Identification of novel molecular markers of pathological complete
response (pCR) to preoperative radiation-based therapy in locally advanced rectal cancer …

TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer

P Lin, C Lin, R He, H Chen, Z Teng, H Yao, S Liu… - Cell death & …, 2023 - nature.com
Colorectal cancer cannot be completely cured at present, and it is still an important clinical
medical problem. TRAF6 is highly expressed in many malignant tumors. However, the role …

RNA sequencing profiles and diagnostic signatures linked with response to ramucirumab in gastric cancer

M Sorokin, E Poddubskaya… - Molecular …, 2020 - molecularcasestudies.cshlp.org
Gastric cancer (GC) is the fifth-ranked cancer type by associated mortality. The proportion of
early diagnosis is low, and most patients are diagnosed at the advanced stages. First-line …

[图书][B] Plants that fight cancer

SE Kintzios, MG Barberaki - 2019 - books.google.com
Plants that Fight Cancer, Second Edition, is a compilation that reviews cancer treatment and
research-based information on the plant kingdom as the source of both known and novel …

Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer

A López-Cortés, C Paz-y-Miño, S Guerrero… - The …, 2020 - nature.com
Colorectal cancer is one of the leading causes of cancer death worldwide. Over the last
decades, several studies have shown that tumor-related genomic alterations predict tumor …

Tissue gene mutation profiles in patients with colorectal cancer and their clinical implications

J Ye, M Lin, C Zhang, X Zhu, S Li, H Liu… - Biomedical …, 2020 - spandidos-publications.com
Colorectal cancer (CRC) is one of the most common types of cancer in the world, and
targeted therapy is frequently used in the clinical management of the disease. A complete …

Nigericin exerts anticancer effects on human colorectal cancer cells by inhibiting Wnt/β-catenin signaling pathway

F Liu, W Li, S Hua, Y Han, Z Xu, D Wan, Y Wang… - Molecular Cancer …, 2018 - AACR
Nigericin, an antibiotic derived from Streptomyces hygroscopicus, which works by acting as
an H+, K+, and Pb2+ ionophore, has exhibited promising anticancer activity. The main …